Together, we'll embark on a journey towards a healthier, happier you
JAMA Network Open, 8 (3), e250186
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound)
Sleep Cycle Regulation 24/7 Customer Support Lab Tested Purity & Quality Ships From Canada Within 24 Hours Free shipping on orders $300 & up Automatically applied at checkout Canada's only domestic premium peptide manufacturer Polar Peptides is Canada's only domestic manufacturer and supplier of premium research peptides, with production and fulfillment handled in Canada
A 2017 review summarised neuroprotective properties of silymarin in animal models, including: Reduction of amyloidogenic activity (relevant in Alzheimer's research) Anti-inflammatory action in nerve tissue Reduction of oxidative stress in the brain Possible positive effects on cognitive function Possible reduction of stroke risk Whether these effects can be achieved in humans at attainable concentrations of silymarin in particular whether sufficient quantities can cross the blood-brain barrier remains unclear
When injected, these benefits extend to vascular endothelium, muscle tissue, and connective structures throughout the body